These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 17368178)
1. Conservative mutageneic perturbations of amino acids connecting helix 12 in the 1alpha,25(OH)2-D3 receptor (VDR) to the ligand cause significant transactivational effects. Bula CM; Bishop JE; Norman AW J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):286-92. PubMed ID: 17368178 [TBL] [Abstract][Full Text] [Related]
2. Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3. Swamy N; Xu W; Paz N; Hsieh JC; Haussler MR; Maalouf GJ; Mohr SC; Ray R Biochemistry; 2000 Oct; 39(40):12162-71. PubMed ID: 11015194 [TBL] [Abstract][Full Text] [Related]
3. The autonomous transactivation domain in helix H3 of the vitamin D receptor is required for transactivation and coactivator interaction. Kraichely DM; Collins JJ; DeLisle RK; MacDonald PN J Biol Chem; 1999 May; 274(20):14352-8. PubMed ID: 10318858 [TBL] [Abstract][Full Text] [Related]
4. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. Masuyama H; Brownfield CM; St-Arnaud R; MacDonald PN Mol Endocrinol; 1997 Sep; 11(10):1507-17. PubMed ID: 9280066 [TBL] [Abstract][Full Text] [Related]
5. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138 [TBL] [Abstract][Full Text] [Related]
6. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes. Ellison TI; Eckert RL; MacDonald PN J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066 [TBL] [Abstract][Full Text] [Related]
7. On the mechanism underlying (23S)-25-dehydro-1alpha(OH)-vitamin D3-26,23-lactone antagonism of hVDRwt gene activation and its switch to a superagonist. Mizwicki MT; Bula CM; Mahinthichaichan P; Henry HL; Ishizuka S; Norman AW J Biol Chem; 2009 Dec; 284(52):36292-36301. PubMed ID: 19801650 [TBL] [Abstract][Full Text] [Related]
8. Hereditary 1,25-dihydroxyvitamin D resistant rickets due to a mutation causing multiple defects in vitamin D receptor function. Malloy PJ; Xu R; Peng L; Peleg S; Al-Ashwal A; Feldman D Endocrinology; 2004 Nov; 145(11):5106-14. PubMed ID: 15308610 [TBL] [Abstract][Full Text] [Related]
9. A novel mutation in helix 12 of the vitamin D receptor impairs coactivator interaction and causes hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia. Malloy PJ; Xu R; Peng L; Clark PA; Feldman D Mol Endocrinol; 2002 Nov; 16(11):2538-46. PubMed ID: 12403843 [TBL] [Abstract][Full Text] [Related]
10. Agonist and antagonist binding to the nuclear vitamin D receptor: dynamics, mutation effects and functional implications. Yaghmaei S; Roberts C; Ai R; Mizwicki MT; Chang CE In Silico Pharmacol; 2013; 1():2. PubMed ID: 25505647 [TBL] [Abstract][Full Text] [Related]
11. Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling. Mizwicki MT; Keidel D; Bula CM; Bishop JE; Zanello LP; Wurtz JM; Moras D; Norman AW Proc Natl Acad Sci U S A; 2004 Aug; 101(35):12876-81. PubMed ID: 15326291 [TBL] [Abstract][Full Text] [Related]
12. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation. Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883 [TBL] [Abstract][Full Text] [Related]
13. Corepressor excess shifts the two-side chain vitamin D analog Gemini from an agonist to an inverse agonist of the vitamin D receptor. Gonzalez MM; Samenfeld P; Peräkylä M; Carlberg C Mol Endocrinol; 2003 Oct; 17(10):2028-38. PubMed ID: 12843209 [TBL] [Abstract][Full Text] [Related]
14. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change. Bula CM; Bishop JE; Ishizuka S; Norman AW Mol Endocrinol; 2000 Nov; 14(11):1788-96. PubMed ID: 11075812 [TBL] [Abstract][Full Text] [Related]
15. A unique insertion/substitution in helix H1 of the vitamin D receptor ligand binding domain in a patient with hereditary 1,25-dihydroxyvitamin D-resistant rickets. Malloy PJ; Xu R; Cattani A; Reyes mL; Feldman D J Bone Miner Res; 2004 Jun; 19(6):1018-24. PubMed ID: 15190891 [TBL] [Abstract][Full Text] [Related]
16. Ligand-mediated conformational changes of the VDR are required for gene transactivation. Carlberg C J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):227-32. PubMed ID: 15225776 [TBL] [Abstract][Full Text] [Related]
17. Hairless modulates ligand-dependent activation of the vitamin D receptor-retinoid X receptor heterodimer. Chuma M; Endo-Umeda K; Shimba S; Yamada S; Makishima M Biol Pharm Bull; 2012; 35(4):582-7. PubMed ID: 22466564 [TBL] [Abstract][Full Text] [Related]
18. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs. Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639 [TBL] [Abstract][Full Text] [Related]
19. Mapping the domains of the interaction of the vitamin D receptor and steroid receptor coactivator-1. Gill RK; Atkins LM; Hollis BW; Bell NH Mol Endocrinol; 1998 Jan; 12(1):57-65. PubMed ID: 9440810 [TBL] [Abstract][Full Text] [Related]
20. Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists. Herdick M; Bury Y; Quack M; Uskokovic MR; Polly P; Carlberg C Mol Pharmacol; 2000 Jun; 57(6):1206-17. PubMed ID: 10825392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]